Dataset from Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Safety And Efficacy Of 2 Doses Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate With Inadequate Response To TNF Inhibitors

NIAID Data Ecosystem2026-05-10 收录

类风湿关节炎药物

JAK抑制剂疗效

数据链接：

https://doi.org/10.25934/00005059 数据链接链接失效反馈

官方服务：

资源简介：

This study will test if CP-690,550 is safe and effective in rheumatoid arthritis patients taking methotrexate who have an inadequate response to tumor necrosis factor inhibitor treatment.

创建时间：

2025-09-22

Dataset from Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Of The Safety And Efficacy Of 2 Doses Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate With Inadequate Response To TNF Inhibitors

资源简介：

相关数据集